IDiyas

For the Inventor, By the Inventor

Lansdale, PA, United States of America

Zhaoyang Meng

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 8.7

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Lansdale, PA (US) (2013 - 2017)
  • Ambler, PA (US) (2020 - 2024)

Company Filing History:

goldMedal15 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal3 out of 10 
 
Msd R&d (china) Co., Ltd.
 patents
where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...
Loading Chart...
15 patents (USPTO):
1. 11970479 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor (2024-04-30),
2. 11655216 - Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use (2023-05-23),
3. 11149036 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor (2021-10-19),
4. 10961215 - N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their use (2021-03-30),
5. 10933056 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor (2021-03-02),
6. 10894775 - Piperidine derivatives as liver X receptor beta agonists, compositions, and their use (2021-01-19),
7. 10752587 - Homobispiperidinyl derivatives as liver X receptor beta agonists, compositions and their use (2020-08-25),
8. 9663506 - Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use (2017-05-30),
9. 9636337 - Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use (2017-05-02),
10. 9227971 - Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors (2016-01-05),
11. 8927562 - Fused tricyclic inhibitors of mammalian target of rapamycin (2015-01-06),
12. 8901142 - Fused tricyclic compounds as mTOR inhibitors (2014-12-02),
13. 8703784 - Substituted pyrazolo[1,5-a]pyrido[3.2-e]pyrimidin-6-one inhibitors of mammalian target of rapamycin (2014-04-22),
14. 8609675 - Fused Tricyclic Compounds as novel mTOR inhibitors (2013-12-17),
15. 8591943 - Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitors (2013-11-26),

Title: The Innovative Journey of Zhaoyang Meng

Introduction:

Zhaoyang Meng, a talented inventor based in Lansdale, PA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents:

Zhaoyang Meng holds several patents in the areas of artificial intelligence, renewable energy, and advanced materials, showcasing his diverse range of expertise and creativity.

Career Highlights:

With a background in engineering and a passion for problem-solving, Zhaoyang Meng has worked for leading tech companies, where he has spearheaded projects that have revolutionized the industry.

Collaborations:

Throughout his career, Zhaoyang Meng has collaborated with top researchers, engineers, and scientists to bring his ideas to life. His ability to work in multidisciplinary teams has led to the successful development of cutting-edge technologies.

Conclusion:

In conclusion, Zhaoyang Meng's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a true visionary in the world of inventions. His impact on the industry is sure to be felt for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…